Cargando…
Orexin Receptor Targets for Anti-Relapse Medication Development in Drug Addiction
Drug addiction is a chronic illness characterized by high rates of relapse. Relapse to drug use can be triggered by re-exposure to drug-associated cues, stressful events, or the drug itself after a period of abstinence. Pharmacological intervention to reduce the impact of relapse-instigating factors...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755900/ https://www.ncbi.nlm.nih.gov/pubmed/23997653 http://dx.doi.org/10.3390/ph4060804 |
_version_ | 1782282006211592192 |
---|---|
author | Zhou, Luyi Sun, Wei-Lun See, Ronald E. |
author_facet | Zhou, Luyi Sun, Wei-Lun See, Ronald E. |
author_sort | Zhou, Luyi |
collection | PubMed |
description | Drug addiction is a chronic illness characterized by high rates of relapse. Relapse to drug use can be triggered by re-exposure to drug-associated cues, stressful events, or the drug itself after a period of abstinence. Pharmacological intervention to reduce the impact of relapse-instigating factors offers a promising target for addiction treatment. Growing evidence has implicated an important role of the orexin/hypocretin system in drug reward and drug-seeking, including animal models of relapse. Here, we review the evidence for the role of orexins in modulating reward and drug-seeking in animal models of addiction and the potential for orexin receptors as specific targets for anti-relapse medication approaches. |
format | Online Article Text |
id | pubmed-3755900 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-37559002013-08-28 Orexin Receptor Targets for Anti-Relapse Medication Development in Drug Addiction Zhou, Luyi Sun, Wei-Lun See, Ronald E. Pharmaceuticals (Basel) Review Drug addiction is a chronic illness characterized by high rates of relapse. Relapse to drug use can be triggered by re-exposure to drug-associated cues, stressful events, or the drug itself after a period of abstinence. Pharmacological intervention to reduce the impact of relapse-instigating factors offers a promising target for addiction treatment. Growing evidence has implicated an important role of the orexin/hypocretin system in drug reward and drug-seeking, including animal models of relapse. Here, we review the evidence for the role of orexins in modulating reward and drug-seeking in animal models of addiction and the potential for orexin receptors as specific targets for anti-relapse medication approaches. MDPI 2011-06-14 /pmc/articles/PMC3755900/ /pubmed/23997653 http://dx.doi.org/10.3390/ph4060804 Text en © 2011 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Review Zhou, Luyi Sun, Wei-Lun See, Ronald E. Orexin Receptor Targets for Anti-Relapse Medication Development in Drug Addiction |
title | Orexin Receptor Targets for Anti-Relapse Medication Development in Drug Addiction |
title_full | Orexin Receptor Targets for Anti-Relapse Medication Development in Drug Addiction |
title_fullStr | Orexin Receptor Targets for Anti-Relapse Medication Development in Drug Addiction |
title_full_unstemmed | Orexin Receptor Targets for Anti-Relapse Medication Development in Drug Addiction |
title_short | Orexin Receptor Targets for Anti-Relapse Medication Development in Drug Addiction |
title_sort | orexin receptor targets for anti-relapse medication development in drug addiction |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755900/ https://www.ncbi.nlm.nih.gov/pubmed/23997653 http://dx.doi.org/10.3390/ph4060804 |
work_keys_str_mv | AT zhouluyi orexinreceptortargetsforantirelapsemedicationdevelopmentindrugaddiction AT sunweilun orexinreceptortargetsforantirelapsemedicationdevelopmentindrugaddiction AT seeronalde orexinreceptortargetsforantirelapsemedicationdevelopmentindrugaddiction |